|
|
|
Insider
Information: |
Schuler Jack W |
Relationship: |
|
City: |
Lake Forest |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
27,956,178 |
|
Indirect Shares
|
61,134,751 |
|
|
Direct
Value |
$198,559,401 |
|
|
Indirect Value
|
$175,231,488 |
|
|
Total
Shares |
89,090,929 |
|
|
Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
54
|
96
|
Stock
price went up :
|
14
|
2
|
Stock
price went down : |
40
|
94
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-25.7%
|
-5,816.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 26
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2017-07-03 |
4 |
B |
$4.00 |
$741,568 |
I/I |
185,392 |
1,383,421 |
1.5 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-08-11 |
4 |
B |
$21.43 |
$1,714,400 |
I/I |
80,000 |
12,483,305 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-08-14 |
4 |
B |
$21.35 |
$499,590 |
I/I |
23,400 |
12,506,705 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-08-15 |
4 |
B |
$21.35 |
$175,070 |
I/I |
8,200 |
12,514,905 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-08-21 |
4 |
B |
$21.34 |
$1,072,347 |
I/I |
50,000 |
12,564,905 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-11 |
4 |
B |
$20.27 |
$1,045,932 |
I/I |
51,600 |
12,616,505 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-12 |
4 |
B |
$19.74 |
$5,452,188 |
I/I |
276,200 |
12,892,705 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-13 |
4 |
B |
$18.81 |
$1,182,228 |
I/I |
61,300 |
12,954,005 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-16 |
4 |
B |
$20.07 |
$1,202,635 |
I/I |
59,922 |
12,981,867 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-17 |
4 |
B |
$20.29 |
$268,843 |
I/I |
13,250 |
12,995,117 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-10-18 |
4 |
B |
$20.14 |
$906,300 |
I/I |
45,000 |
13,040,117 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-06 |
4 |
B |
$18.51 |
$6,311,293 |
I/I |
340,964 |
1,293,642 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-07 |
4 |
B |
$18.73 |
$936,500 |
I/I |
50,000 |
1,343,642 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-08 |
4 |
B |
$18.46 |
$923,000 |
I/I |
50,000 |
1,393,642 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-09 |
4 |
B |
$18.54 |
$493,164 |
I/I |
26,600 |
1,420,242 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-10 |
4 |
B |
$18.81 |
$462,369 |
I/I |
24,581 |
1,444,823 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-13 |
4 |
B |
$18.98 |
$379,600 |
I/I |
20,000 |
1,464,823 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-14 |
4 |
B |
$19.19 |
$191,900 |
I/I |
10,000 |
1,474,823 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-15 |
4 |
B |
$20.80 |
$208,000 |
I/I |
10,000 |
1,484,823 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-16 |
4 |
B |
$21.18 |
$211,800 |
I/I |
10,000 |
1,494,823 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2017-11-17 |
4 |
B |
$22.00 |
$121,000 |
I/I |
5,500 |
1,500,323 |
2.25 |
- |
|
YTEN |
Yield10 Bioscience Inc |
10% Owner |
|
2017-12-19 |
4 |
B |
$2.26 |
$4,309,241 |
I/I |
1,906,744 |
3,270,481 |
1.5 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2018-02-20 |
4 |
B |
$24.95 |
$499,000 |
I/I |
20,000 |
13,145,028 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2018-02-21 |
4 |
B |
$25.16 |
$251,600 |
I/I |
10,000 |
13,155,028 |
2.25 |
- |
|
AXDX |
Accelr8 Technology Corp |
Director |
|
2018-02-22 |
4 |
B |
$25.21 |
$252,100 |
I/I |
10,000 |
13,165,028 |
2.25 |
- |
|
634 Records found
|
|
Page 9 of 26 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|